Meet the team

Find out about the incredible team that are working together to improve care in the operating room.

A little bit of history

Co-founders Tom Carrell, a vascular surgeon in London and Graeme Penney, an imaging scientist at King’s College London, formed Cydar in 2012 to solve a true clinical problem: the need for better visualization of the anatomy during endovascular surgery. Since then, Carrell and Penney have been turning world-leading image processing research into a world first in cloud-based healthcare.

Tom Carrell

Chief Executive and Co-Founder

Tom was appointed a consultant vascular surgeon in 2004. Specialising in minimally-invasive endovascular surgery, he established and led the complex aortic programme at Guy’s and St Thomas’ Hospitals in London before becoming full-time CEO of Cydar in 2014.

Ben Wicks

Chief Operating Officer

Ben is an experienced and entrepreneurial device development expert with more than 20 years’ experience in the business, science and engineering of medical technology. Ben has a PhD in Clinical Biochemistry and has worked with a variety of blue chip and start-up companies on products across a range of areas including surgery, in vitro diagnostics and drug delivery.

Graeme Penney

Chief Scientific Officer and Co-Founder

Graeme is a Senior Lecturer in Imaging Sciences in the Department of Biomedical Engineering at King’s College London. He has published extensively in the field of 2D-3D image registration and is co-inventor on a number of patents in this field.

Helen Rae

Chief Financial Officer

Helen is an experienced finance professional having worked in the Cambridge high growth sector for fifteen years. Prior to joining us, she worked for a number of companies including start-ups and public companies in senior finance roles. She is a chartered accountant and fellow of the ICAEW having trained and qualified with Deloitte.

Rob Hague

Chief Technology Officer

Rob brings over 15 years of experience in both research and product development, ranging from user interfaces and ubiquitous computing to low-level application infrastructure and algorithm implementation.

Paul Hardwick

Commercial Director

Paul is an experienced International Sales and Marketing Professional with over 18 years in the medical device industry. He has previously held leadership roles with Oxford Medtech, Lombard Medical and Boston Scientific, directing the strategic & operational commercial business across Europe, Asia-Pacific and Latin America.

Steve Toon

Head of Marketing

Steve brings over 15 years in the healthcare industry. He has worked for a range of companies, from start-ups to global corporations. Prior to joining us, he has held a number of marketing roles with specific focus on commercialising technologies that enhance minimally invasive surgery.

Non-executive directors

Lord Davies of Abersoch

Lord Mervyn Davies brings commercial and international experience to the Board as both a former CEO and Chairman of Standard Chartered Bank, former Minister for Trade, Investment, Small Business and Infrastructure and as current Chairman of Corsair Capital and a Director across a diverse range of companies.

John E. Deanfield

Professor Deanfield brings expertise in cardiovascular imaging, large-scale clinical trials and outcomes research, both nationally and internationally. He is Professor of Cardiology at University College London and Director of the National Institute for Cardiovascular Outcomes Research (NICOR).

Mark Evans

Mark Evans is co-founder and CEO of Adaptix Ltd and co-founder and former Chairman of Mirada Medical, both UK medical imaging companies. Mark brings expert knowledge and experience of the global medical imaging sector and a strong network within the domain.

James B. Downing

James Downing brings extensive deal structuring and negotiating skills as a corporate finance specialist, and former Deputy Head of European Investment Banking at JP Morgan Chase & Co and currently as Non-Executive Director on a number of companies.

Franz B. Humer

Dr Franz B. Humer brings a wealth of healthcare and commercialisation experience as well as deep insights into clinical applications and health data. He is former CEO and Chairman of Roche Plc, having previously been at Glaxo and Schering Plough.

David Renton

David is Finance Director of Guy's and St Thomas' Charity, which is a major funder of healthcare innovation in Lambeth and Southwark.

Our partners

Guy's & St Thomas' Charity Kings College London Guy's & St Thomas' NHS Foundation Trust Cambridge Capital Group Innovate UK Kent Investors Network